More about

Thrombophilia

News
February 24, 2025
3 min read
Save

Blood clot risk varies by hormonal contraception type used, personalized counseling needed

Blood clot risk varies by hormonal contraception type used, personalized counseling needed

A woman’s risk for blood clots varied by the type of hormonal contraception used, according to a nationwide cohort study conducted in Denmark.

News
March 26, 2024
2 min read
Save

Migraine, nontraditional factors likely contribute to stroke risk in young adults

Migraine, nontraditional factors likely contribute to stroke risk in young adults

Nontraditional risk factors such as migraine, valvular heart disease and thrombophilia may be linked to increased risk for stroke among younger adults, researchers reported.

News
December 21, 2023
3 min read
Save

ASH panel provides ‘weak’ recommendations for thrombophilia testing

ASH panel provides ‘weak’ recommendations for thrombophilia testing

Women with venous thromboembolism associated with pregnancy, the postpartum period or combined oral contraceptives who have finished primary short-term treatment may be considered for thrombophilia testing.

News
July 17, 2023
4 min read
Save

ASH guidelines on thrombophilia testing ‘could change practice’

ASH guidelines on thrombophilia testing ‘could change practice’

Thrombophilia is a known risk factor for venous thromboembolism, but the value of thrombophilia testing in guiding treatment decisions remains a topic of debate.

News
December 29, 2022
1 min read
Save

Top in hem/onc: Blood thinners in women with miscarriage history; breast cancer risks

Top in hem/onc: Blood thinners in women with miscarriage history; breast cancer risks

Recent data suggest that the use of blood thinners may be unnecessary in women with a history of recurrent pregnancy loss and inherited thrombophilia, according to researchers.

News
December 21, 2022
2 min read
Save

Use of blood thinners may be unnecessary in women with recurrent pregnancy loss

Use of blood thinners may be unnecessary in women with recurrent pregnancy loss

NEW ORLEANS — The use of low-molecular-weight heparin among pregnant women with a history of recurrent miscarriage and inherited thrombophilia had no effect on the live birth rate, results from the phase 3 ALIFE2 trial showed.